Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 608 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32022R0692

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2022/692

xx xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx pro xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx nařízení Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 o klasifikaci, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx

(Xxxx x&xxxx;xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x&xxxx;xxxxxxx na Smlouvu x&xxxx;xxxxxxxxx Evropské xxxx,

x&xxxx;xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 o klasifikaci, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (ES) č. 1907/2006 (1), x&xxxx;xxxxxxx xx čl. 37 xxxx.&xxxx;5 uvedeného xxxxxxxx,

xxxxxxxx x&xxxx;xxxxx důvodům:

(1)

Tabulka 3 x&xxxx;xxxxx 3 přílohy XX nařízení (XX) x.&xxxx;1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxxxxx xxxxx na xxxxxxx kritérií xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx I uvedeného xxxxxxxx.

(2)

Xxxxxxxx xxxxxxxx pro xxxxxxxx xxxxx (xxxx xxx „xxxxxxxx“) xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxxxx xxxxxx xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx zrušení xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx jiných xxxxx. Xxxx, xx Výbor xxx posuzování rizik (XXX) xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx xxxxx, xxxxxx k těmto xxxxxxx xxxxxxxxxxx stanoviska (2):

—

stanovisko xx xxx 5. prosince 2019 xxx xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, produkty xxxxxxxxx s oxidem xxxxxxxxxx; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx,

—

xxxxxxxxxx xx xxx 4. května 2020 pro xxxxxxxxxx (XXX), [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx β-xxxxxxxxxx (XXX); xxxxxxx xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (ISO); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-chlor-3-pyridyl)methyl]-N 2-xxxx-X 1-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx tellur,

—

stanovisko xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx oxid xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11. června 2020 xxx tribromderivát 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx piperonylbutoxid (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx daminozid (XXX); 4-(2,2-dimethylhydrazino)-4-oxobutanovou kyselinu; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx kyselinu,

—

stanovisko ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (ISO); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx fluopikolid (ISO); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx trichlorsilan,

—

stanovisko xx dne 11. června 2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 ohledně xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxxx xxxx na xxxxxx Xxxxxxxx xxxxxx,

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 pro 4,4’-xxxxx(xxxxxxxxxxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx toluen-4-sulfonohydrazid,

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxx; 1,3-dimethyl-3,7-dihydro-1H-purin-2,6-dion,

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [m-TMXDI],

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI],

—

stanovisko xx xxx 17. září 2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx triamid xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 2-ethyl-2-{[(1-oxoallyl)oxy]methyl}propan-1,3-diyl-diakrylát; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; trimethylolpropan-triakrylát,

—

stanovisko xx xxx 17. září 2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx než 50 μm],

—

stanovisko xx xxx 17. září 2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující ≥ 0,1 % xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μm],

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxx xxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro 2,4,6-xxx-xxxx-xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 xxx pyridalyl (XXX); 2,6-dichlor-4-(3,3-dichlorallyloxy)fenyl{3-[5-(trifluormethyl)-2-pyridyloxy]propyl}ether,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxx-2-xxxxx-1-xxxx, xxxxxx xxx; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx sodný,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8. října 2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; diethylenglykolmonomethylether,

—

stanovisko xx xxx 8. října 2020 xxx 4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx pendimethalin (ISO); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—

xxxxxxxxxx ze dne 8.&xxxx;xxxxx&xxxx;2020 xxx dimoxystrobin (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid,

—

stanovisko xx xxx 10. prosince 2020 xxx 4,4’-xxxxxxxxxxxxxxx; bisfenol X,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro 2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Blue 124,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx xxxxxxxxxxxxxxxxxx; xxxxxxxx xxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx 6-[xxxxx-(X10-X13, rozvětvené, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-xxxxxxx-2,4,6-xxxxxxx; melamin,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxx směs: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥ 78 % xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxx, extraktu [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx, extrahovaný xxxxx x&xxxx;xxxx zpracovaný xxxxxxxxxxx xxxxxxxxxxxx],

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx (XXX), 3-xxxxxxxxx-2,1,3-xxxxxxxxxxxxxxx-4-xx-2,2-xxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 ohledně xxxxxxxxxx posouzení nových xxxxxxxxx o akutní inhalační xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx xxxxxx.

(3)

Xxxx obdrženy xxxxxxxxx xxxxxxxxx, které xxxxxxxxxxx vědecké posouzení xxxxxxx xx xxxxxxxxxxxx XXX xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-ethylhexanovou xxxxxxxx x&xxxx;xxxx soli; xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx a jejích xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxxx xxxx na xxxxxx Evropské komise, xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx xxxxxx, xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx vanadičný, xx xxx 10. prosince 2020 xxxxxxx xxxxxxxxxx posouzení xxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (EGBE) xx xxxxxx Xxxxxxxx xxxxxx x&xxxx;xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx melamin.

(4)

Komise tyto xxxxxxxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx xx za xxxxxxxxxx x&xxxx;xxxx, xxx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx ve xxxxxxxxxxxx XXX. Xx xxxxxxx xxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx xx xxxxx xxxxxx xxxxxx, xxxxxxxxxxxx xxxx xxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxx.

(5)

Xxxx, xx bylo Xxxxxx xxxxxxx xxxxxxxxxx XXX, byly obdrženy xxxxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx oxidu xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx. Xxxxxxxxxxx silanaminu, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx syntetického xxxxxxxxx xxxxx křemičitého x&xxxx;xxxxxxxxx s povrchovou xxxxxxx xxxx akutní xxxxxxxxx xxxxxxxx kategorie 2, xxxxxxxxxx xx xxxxxxxxxx XXX xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019, by xxxxxx xxx zařazena xx xxxxxxx VI xxxxxxxx (XX) x.&xxxx;1272/2008, xxxxx Xxxxxx nové vědecké xxxxxxxxx xxxxxxxxx a neshledala, xx xx xxxx xxxxx xxxxx xxxxxxxxx XXX. Do přílohy XX nařízení (ES) x.&xxxx;1272/2008 xx xxxx xxxx být xxxxxxxx xxxxxxxxxxx xxxx xxxxx xxxx STOT XX 2, doporučená ve xxxxxxxxxx xxxxxx XXX xx xxx 5. prosince 2019, xxxxx nebyly xxxxxxxx xxxxx xxxx xxxxxxxxx, xxxxx xx vyžadovaly xxxxx xxxxxxxxx této xxxxxxxxxxx.

(6)

Xxxxxxxx (XX) č. 1272/2008 xx xxxxx mělo xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx xxxx xxxxxxxxxxxxxxx harmonizovaných xxxxxxxxxxx xx nemělo být xxxxxxxxxx xxxxx, xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx xxxx na xx, xxx xxxxxxxxxxxx označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx xxxxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxx xxxxxxxxx xxxxxx, na xxxxx xx vztahují xxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Xxxx xxxx xx rovněž xxxxxxxx x&xxxx;xxxx, xxx xxxxxxxxxx měli xxxxxxxx xxxx přijmout xxxxxxxx xxxxx x&xxxx;xxxxxxxxx trvalého xxxxxxxxxx dalších právních xxxxxxxxx, xxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxx xxxxxxxxxxx xxxxx tohoto xxxxxxxx. Xxxxxxxxxxx xx xxxx xxxx xxx xxxxxxxx xxxxxxxx nové xxxx xxxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxxxx přizpůsobit xxxxxxxxxx x&xxxx;xxxxxx xx xxxxxxxxxxx xxxxxxx xxxx xxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxx, xxx xxxx xxxxxxxxx xxxxxx úroveň xxxxxxx lidského xxxxxx x&xxxx;xxxxxxxxx xxxxxxxxx x&xxxx;xxx xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX TOTO XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Xxxxxxx VI xxxxxxxx (XX) x.&xxxx;1272/2008 se xxxx v souladu x&xxxx;xxxxxxxx xxxxxx xxxxxxxx.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxx

Xxxx xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx dnem xx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx se xxx xxx 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx xx druhého xxxxxxxxxxx tohoto xxxxxx xxxxx být látky x&xxxx;xxxxx xxxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx s tímto xxxxxxxxx ode xxx xxxx xxxxxx v platnost.

Toto xxxxxxxx je xxxxxxx v celém xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx členských státech.

V Bruselu xxx 16.&xxxx;xxxxx 2022.

Za Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX DER XXXXX

(1)&xxxx;&xxxx;Xx. xxxx. L 353, 31.12.2008, s. 1.

(2)  Stanoviska xxxx xxxxxxxx na xxxx xxxxxxxxxxx xxxxxxx: https://echa.europa.eu/registry-of-clh-intentions-until-outcome/-/dislist/name/-/ecNumber/-/casNumber/-/dte_receiptFrom/-/dte_receiptTo/-/prc_public_status/Opinion+Adopted/dte_withdrawnFrom/-/dte_withdrawnTo/-/sbm_expected_submissionFrom/-/sbm_expected_submissionTo/-/dte_finalise_deadlineFrom/-/dte_finalise_deadlineTo/-/haz_addional_hazard/-/lec_submitter/-/dte_assessmentFrom/-/dte_assessmentTo/-/prc_regulatory_programme/-/. – Xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 x&xxxx;xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxxx xx opětovného posouzení xx xxxxxx Xxxxxxxx xxxxxx xxxx k dispozici xx xxxx internetové xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

XXXXXXX

Xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 xx xxxx xxxxx:

1)

x&xxxx;xxxxx 3 xx xxxxxxx 3 xxxx takto:

a)

vkládají xx xxxx položky:

Indexové xxxxx

Xxxxxxxx xxxxx

Xxxxx ES

Číslo CAS

Klasifikace

Označení

Specifické xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE

Poznámky

Kódy tříd x&xxxx;xxxxxxxxx nebezpečnosti

Kódy standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx výstražných xxxxxxx a signálních xxxx

Xxxx xxxxxxxxxxxx vět o nebezpečnosti

Kódy xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-052-00-7

xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx křemičitým; xxxxxxxxx syntetický xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx

272-697-1

68909-20-6

XXXX XX 2

X373 (xxxxx) (xxxxxxxxxx)

XXX08

Xxx

X373 (xxxxx) (vdechování)

EUH066“

„035-005-00-7

bromid xxxxxx

235-183-8

12124-97-9

Xxxx. 1X

Xxxx.

XXXX XX 3

XXXX XX 1

Eye Xxxxx. 2

X360XX

X362

X336

X372 (nervový xxxxxx)

X319

XXX08

XXX07

Xxx

X360XX

X362

X336

X372 (xxxxxxx systém)

H319“

„050-032-00-4

dibutylcín-bis(2-ethylhexanoát)

220-481-2

2781-10-4

Muta. 2

Xxxx. 1X

XXXX RE 1

X341

X360XX

X372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„050-033-00-X

xxxxxxxxxx-xxxxxxxx

213-928-8

1067-33-0

Xxxx. 2

Repr. 1B

STOT XX 1

X341

X360XX

X372 (imunitní xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„052-001-00-0

xxxxxx

236-813-4

13494-80-9

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„052-002-00-6

xxxx xxxxxxxxxxx

231-193-1

7446-07-3

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„056-005-00-3

xxxxxxxxx xxxxxxx-xxxxxxxx

237-222-4

13701-59-2

Xxxx. 1X

Xxxxx Xxx. 4

Xxxxx Tox. 3

X360XX

X332

X301

XXX08

XXX06

Xxx

X360XX

X332

X301

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 100&xxxx;xx/xx TH“

„601-097-00-8

propylbenzen

203-132-9

103-65-1

Flam. Xxx. 3

Xxx. Tox. 1

XXXX SE 3

Xxxxxxx Xxxxxxx 2

X226

X304

X335

X411

XXX02

XXX08

XXX07

XXX09

Xxx

X226

X304

X335

X411“

„603-243-00-6

xxxxxxxxxxxxxx 2,2-dimethylpropan-1-olu; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx

253-057-0

36483-57-5; 1522-92-5

Carc. 1X

Xxxx. 2

X350

X341

XXX08

Xxx

X350

X341“

„604-096-00-0

xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx

200-076-7

51-03-6

XXXX XX 3

Eye Irrit. 2

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X335

X319

X400

X410

XXX07

XXX09

Xxx

X335

X319

X410

XXX066

X&xxxx;= 1

X&xxxx;= 1“

„604-097-00-6

2,4,6-xxx-xxxx-xxxxxxxxxx

211-989-5

732-26-3

Xxxx. 1B

Acute Xxx. 4

XXXX RE 2

Skin Xxxx. 1B

H360D

H302

H373 (xxxxx)

X317

XXX08

XXX07

Xxx

X360X

X302

X373 (xxxxx)

X317

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX“

„604-098-00-1

4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X

201-250-5

80-09-1

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„606-153-00-5

xxxxxxxxxx

204-337-6

119-61-9

Xxxx. 1X

X350

XXX08

Xxx

X350“

„606-154-00-0

xxxxxxxxxxx (XXX); 2-amino-3-chlor-1,4-naftochinon

220-529-2

2797-51-5

Carc. 2

Xxxx. 2

Xxxxx Xxx. 4

XXXX XX 2

Eye Xxxxx. 2

Xxxx Sens. 1&xxxx;X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H302

H373 (xxxxxx xxxx, xxxxxxx)

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X361x

X302

X373 (krevní xxxx, ledviny)

H319

H317

H410

orální:

ATE = 500 mg/kg XX

X&xxxx;= 10

M = 10“

„607-756-00-6

xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx

227-561-6

5888-33-5

Xxxx Xxxx. 1 A

H317

GHS07

Wng

H317“

„607-757-00-1

daminozid (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx

216-485-9

1596-84-5

Xxxx. 2

X351

XXX08

Xxx

X351“

„607-758-00-7

4,4′-xxxxx(xxxxxxxxxxxxxxxxxxxxx)

201-286-1

80-51-3

Xxxx-xxxxx. X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X242

X400

X410

XXX02

XXX09

Xxx

X242

X410

X&xxxx;= 1

X&xxxx;= 1“

„607-759-00-2

xxxxxx-4-xxxxxxxxxxxxxxx

216-407-3

1576-35-8

Xxxx-xxxxx. D

H242

GHS02

Dgr

H242“

„607-760-00-8

2-{N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino}ethyl-acetát; C.I. Xxxxxxxx Xxxx 124

239-203-6

15141-18-1

Skin Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317

Xxxx Xxxx. 1&xxxx;X; X317: C ≥ 0,001 %“

„607-761-00-3

perfluorheptanová xxxxxxxx; tridekafluorheptanová xxxxxxxx

206-798-9

375-85-9

Xxxx. 1X

XXXX XX 1

X360X

X372 (xxxxx)

XXX08

Xxx

X360X

X372 (játra)“

„607-762-00-9

methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; valifenalát

-

283159-90-0

Carc. 2

Xxxxxxx Xxxxxxx 2

X351

X411

XXX08

XXX09

Xxx

X351

X411“

„607-763-00-4

6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx, xxxxx a tris(2-hydroxyethyl)amonné xxxx

-

-

Xxxx. 1X

Xxx Xxxxx. 2

X360XX

X319

XXX08

XXX07

Xxx

X360XX

X319“

„607-764-00-X

6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx kyselina

-

2156592-54-8

Repr. 1X

Xxx Xxxxx. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-765-00-5

6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx

-

-

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„613-341-00-0

xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx

277-728-2

74115-24-5

Xxxxxxx Xxxxxxx 1

X410

XXX09

Xxx

X410

X&xxxx;= 1“

„613-342-00-6

xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx

200-385-7

58-55-9

Xxxx. 1B

H360D

GHS08

Dgr

H360D“

„613-343-00-1

pyridalyl (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx

-

179101-81-6

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1 000

M = 100“

„613-344-00-7

pyridin-2-thiol-1-oxid, xxxxx xxx; sodná xxx xxxxxxxxxx; xxxxxxxxx xxxxx

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Acute Xxx. 4

XXXX RE 1

Skin Xxxxx. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Aquatic Xxxxxxx 2

X331

X311

X302

X372 (nervový xxxxxx)

X315

X319

X317

X400

X411

XXX06

XXX08

XXX09

Xxx

X331

X311

X302

X372 (xxxxxxx systém)

H315

H319

H317

H410

EUH070

inhalační:

ATE = 0,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxxxx:

XXX&xxxx;= 790&xxxx;xx/xx XX

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 100“

„613-345-00-2

1,3,5-xxxxxxx-2,4,6-xxxxxxx;

xxxxxxx

203-615-4

108-78-1

Xxxx. 2

XXXX XX 2

H351

H373 (xxxxxx xxxxx)

XXX08

Xxx

X351

X373 (močové xxxxx)“

„615-046-00-2

1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX]

220-474-4

2778-42-9

Xxxx. Xxxx. 1

Xxxx Xxxx. 1 A

H334

H317

GHS08

Dgr

H334

H317“

„615-047-00-8

1,3-bis(isokyanatomethyl)benzen; [x-XXX]

222-852-4

3634-83-1

Xxxx. Xxxx. 1

Skin Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317

Xxxx Sens. 1&xxxx;X; X317: C ≥ 0,001 %“

„615-048-00-3

2,4,6-triisopropyl-m-fenylen-diisokyanát

218-485-4

2162-73-4

Resp. Sens. 1

Xxxx Xxxx. 1

X334

X317

XXX08

Xxx

X334

X317“

„615-049-00-9

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% hmot. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μx]

221-641-4

3173-72-6

XXXX XX 3

Xxxx Irrit. 2

Xxx Xxxxx. 2

Resp. Xxxx. 1

Skin Sens. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

X335

X315

X319

X334

X317

X412

XXX07

XXX08

Xxx

X335

X315

X319

X334

X317

X412“

„615-050-00-4

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx]

221-641-4

3173-72-6

Xxxxx Xxx. 2

XXXX SE 3

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Xxxx. Xxxx. 1

Xxxx Xxxx. 1 A

Aquatic Xxxxxxx 3

X330

X335

X315

X319

X334

X317

X412

XXX06

XXX08

Xxx

X330

X335

X315

X319

X334

X317

X412

xxxxxxxxx:

XXX&xxxx;= 0,27&xxxx;xx/x (xxxxx xxxx xxxx)“

„616-237-00-3

xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx

-

239110-15-7

Xxxx. 2

X361x

XXX08

Xxx

X361x“

„616-238-00-9

xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx

477-690-9

874819-71-3

Xxxx. 1X

XXXX XX 2

X360Xx

X373 (ledviny)

GHS08

Dgr

H360Fd

H373 (xxxxxxx)“

„616-239-00-4

X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx

-

1255734-28-1

Xxxx. 2

Xxxxx Xxx. 4

Skin Xxxx. 1X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

H361f

H332

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f

H332

H317

H410

inhalační:

ATE = 2,2&xxxx;xx/x (xxxxx xxxx xxxx)

X&xxxx;= 10

X&xxxx;= 1“

„616-240-00-X

xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], isopyrazam

-

881685-58-1

Carc. 2

Xxxx. 1X

Xxxx Xxxx. 1X

Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1

H351

H360D

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H317

H410

Repr. 1X; X360X:

X&xxxx;≥&xxxx;3&xxxx;%

X&xxxx;= 10

M = 10“

„650-058-00-1

Xxxxxxx, extrakt [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx]

283-644-7

84696-25-3

Xxxx. 2

Xxxx Sens. 1

Aquatic Xxxxxxx 1

H361d

H317

H410

GHS08

GHS07

GHS09

Wng

H361d

H317

H410

M = 10“

x)

xxxxxxx xxxxxxxxxxxx xxxxxxxxx číslům 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 xx xxxxxxxxx těmito xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx název

Číslo ES

Číslo XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE

Poznámky

Kódy xxxx a kategorií xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-001-00-9

xxxxxxxxxxxxx

233-042-5

10025-78-2

Xxxx. Liq. 1

Xxxxx-xxxxx. 1

Xxxxx Tox. 3

Xxxxx Xxx. 4

Skin Xxxx. 1 A

Eye Dam. 1

X224

X260

X331

X302

X314

X318

XXX02

XXX06

XXX05

Xxx

X224

X260

X331

X302

X314

XXX014

XXX029

XXX071

xxxxxxxxx:

XXX&xxxx;= 7,6 mg/l (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;000 &xxxx;xx/xx XX“

„023-001-00-8

xxxx xxxxxxxxx

215-239-8

1314-62-1

Xxxx. 2

Xxxx. 1X

Xxxx. 2

Xxxx.

Xxxxx Xxx. 3

Acute Xxx. 2

STOT XX 3

XXXX XX 1

Aquatic Xxxxxxx 2

X341

X350

X361xx

X362

X301

X330

X335

X372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

XXX06

XXX08

XXX09

Xxx

X341

X350

X361xx

X362

X301

X330

X335

X372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

xxxxxxxxx:

XXX&xxxx;= 0,05&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 220&xxxx;xx/xx XX“

„601-024-00-X

xxxxx

202-704-5

98-82-8

Xxxx. Liq. 3

Xxxx. 1X

Xxx. Xxx. 1

XXXX XX 3

Xxxxxxx Xxxxxxx 2

H226

H350

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H350

H304

H335

H411“

„603-014-00-0

2-butoxyethan-1-ol; xxxxxxxxxxxxx-xxxxxxxxx-xxxxx

203-905-0

111-76-2

Xxxxx Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

X331

X302

X315

X319

XXX06

Xxx

X331

X302

X315

X319

xxxxxxxxx:

XXX&xxxx;= 3&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;200  mg/kg XX“

„603-107-00-6

2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

203-906-6

111-77-3

Xxxx. 1X

X360X

XXX08

Xxx

X360X

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%“

„604-030-00-0

4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx A

201-245-8

80-05-7

Repr. 1B

STOT XX 3

Eye Xxx. 1

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X360X

X335

X318

X317

X400

X410

XXX08

XXX07

XXX05

XXX09

Xxx

X360X

X335

X318

X317

X410

X&xxxx;= 1

X&xxxx;= 10“

„607-111-00-9

2-ethyl-2-{[(1-oxoallyl)oxy]methyl}propan-1,3-diyl-diakrylát; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx;

xxxxxxxxxxxxxxxxx-xxxxxxxxxx

239-701-3

15625-89-5

Xxxx. 2

Xxxx Irrit. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X351

X315

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X315

X319

X317

X410

X&xxxx;= 1

X&xxxx;= 1

D“

„607-230-00-6

2-ethylhexanová kyselina x&xxxx;xxxx soli, x&xxxx;xxxxxxxx xxxx, které xxxx xxxxxxx jinde x&xxxx;xxxx xxxxxxx

-

-

Xxxx. 1B

H360D

GHS08

Dgr

H360D“

„607-253-00-1

cyfluthrin (XXX); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

269-855-7

68359-37-5

Xxxx.

Xxxxx Xxx. 2

Acute Xxx. 2

STOT XX 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,14&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 14&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1 000 000 “

„607-254-00-7

β-xxxxxxxxxx (XXX); reakční xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

-

1820573-27-0

Xxxx.

Xxxxx Tox. 2

Xxxxx Tox. 2

XXXX XX 1

Aquatic Xxxxx 1

Xxxxxxx Chronic 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (nervový xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,081 mg/l (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 11&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1 000 000 “

„607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx

404-290-3

7216-95-7

Xxxx. 1X

Xxxxx Xxx. 4

STOT XX 2

Xxx Xxxxx. 2

H360D

H332

H373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1B; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-735-00-1

{[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx

200-652-8

67-43-6

Xxxx. 1X

Xxxxx Tox. 4

XXXX RE 2

Xxx Xxxxx. 2

H360D

H332

H373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1B; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5 mg/l (xxxxx xxxx xxxx)“

„607-736-00-7

xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]

205-391-3

140-01-2

Xxxx. 1X

Xxxxx Xxx. 4

XXXX RE 2

X360X

X332

X373 (vdechování)

GHS08

GHS07

Dgr

H360D

H332

H373 (xxxxxxxxxx)

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx nebo xxxx)“

„608-032-00-2

xxxxxxxxxxx (ISO); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-kyan-N 1-xxxxxxxxxxxxxxxx

-

135410-20-7&xxxx;160430-64-8

Xxxx. 2

Xxxxx Tox. 3

Xxxxxxx Xxxxxxx 1

Xxxxxxx Xxxxx 1

X361x

X301

X410

X400

XXX08

XXX06

XXX09

Xxx

X361x

X301

X410

xxxxxx:

XXX&xxxx;= 140&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„609-042-00-X

pendimethalin (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx

254-938-2

40487-42-1

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 100

X&xxxx;= 10“

„613-012-00-1

bentazon (XXX); 3-xxxxxxxxx-1X-2,1,3-xxxxxxxxxxxxxxx-4(3X)-xx-2,2-xxxxxx

246-585-8

25057-89-0

Xxxx. 2

Xxxxx Xxx. 4

Xxx Xxxxx. 2

Xxxx Sens. 1

H361d

H302

H319

H317

GHS08

GHS07

Wng

H361d

H302

H319

H317

orální: XXX&xxxx;= 1&xxxx;600 &xxxx;xx/xx XX“

„616-164-00-7

xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

Xxxx. 2

Repr. 2

Xxxxx Xxx. 4

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H332

H410

inhalační:

ATE = 1,3&xxxx;xx/x (prach xxxx xxxx)

X&xxxx;= 100

X&xxxx;= 100“

c)

položka xxxxxxxxxxxx xxxxxxxxxx číslu 615-007-00-X xx zrušuje.